| Empagliflozin ameliorates adverse left ventricular remodeling in nondiabetic heart failure by enhancing myocardial energetics CG Santos-Gallego, JA Requena-Ibanez, R San Antonio, K Ishikawa, ... Journal of the American College of Cardiology 73 (15), 1931-1944, 2019 | 500 | 2019 |
| Empagliflozin ameliorates diastolic dysfunction and left ventricular fibrosis/stiffness in nondiabetic heart failure: a multimodality study CG Santos-Gallego, JA Requena-Ibanez, R San Antonio, ... Cardiovascular Imaging 14 (2), 393-407, 2021 | 133 | 2021 |
| Personalized paroxysmal atrial fibrillation ablation by tailoring ablation index to the left atrial wall thickness: the ‘Ablate by-LAW’single-centre study—a pilot study C Teres, D Soto-Iglesias, D Penela, B Jáuregui, A Ordoñez, A Chauca, ... EP Europace 24 (3), 390-399, 2022 | 39 | 2022 |
| Empagliflozin induces a myocardial metabolic shift from glucose consumption to ketone metabolism that mitigates adverse cardiac remodeling and improves myocardial contractility CG Santos-Gallego, JAR Ibanez, RS Antonio, K Ishikawa, S Watanabe, ... Journal of the American College of Cardiology 71 (11S), A674-A674, 2018 | 39 | 2018 |
| Out-of-hospital cardiac arrest and stent thrombosis: Ticagrelor versus clopidogrel in patients with primary percutaneous coronary intervention under mild therapeutic hypothermia G Jiménez-Brítez, X Freixa, E Flores-Umanzor, R San Antonio, G Caixal, ... Resuscitation 114, 141-145, 2017 | 39 | 2017 |
| Ventricular tachycardia burden reduction after substrate ablation: predictors of recurrence L Quinto, P Sanchez-Somonte, F Alarcón, P Garre, À Castillo, ... Heart Rhythm 18 (6), 896-904, 2021 | 26 | 2021 |
| Very high pacing thresholds during long‐term follow‐up predicted by a combination of implant pacing threshold and impedance in leadless transcatheter pacemakers JM Tolosana, E Guasch, R San Antonio, J Apolo, M Pujol‐López, ... Journal of Cardiovascular Electrophysiology 31 (4), 868-874, 2020 | 24 | 2020 |
| Serum levels of Growth Arrest-Specific 6 protein and soluble AXL in patients with ST-segment elevation myocardial infarction G Caldentey, P García De Frutos, H Cristóbal, M Garabito, A Berruezo, ... European Heart Journal: Acute Cardiovascular Care 8 (8), 708-716, 2019 | 24 | 2019 |
| Electrocardiographic optimization techniques in resynchronization therapy M Pujol-López, R San Antonio, L Mont, E Trucco, JM Tolosana, E Arbelo, ... EP Europace 21 (9), 1286-1296, 2019 | 22 | 2019 |
| Cardiovascular magnetic resonance determinants of ventricular arrhythmic events after myocardial infarction B Jáuregui, D Soto-Iglesias, D Penela, J Acosta, J Fernández-Armenta, ... Europace 24 (6), 938-947, 2022 | 19 | 2022 |
| Magnetic resonance-guided re-ablation for atrial fibrillation is associated with a lower recurrence rate: a case–control study L Quinto, J Cozzari, E Benito, F Alarcón, F Bisbal, O Trotta, G Caixal, ... EP Europace 22 (12), 1805-1811, 2020 | 19 | 2020 |
| Effect of pulmonary artery denervation in postcapillary pulmonary hypertension: results of a randomized controlled translational study I Garcia-Lunar, D Pereda, E Santiago, N Solanes, J Nuche, M Ascaso, ... Basic Research in Cardiology 114, 1-15, 2019 | 18 | 2019 |
| Diuretic strategies in acute heart failure and renal dysfunction: conventional vs carbohydrate antigen 125-guided strategy. Clinical trial design S Garcia-Blas, C Bonanad, P Llacer, S Ventura, JM Núñez, R Sanchez, ... Revista Española de Cardiología (English Edition) 70 (12), 1067-1073, 2017 | 16 | 2017 |
| Personalized pulmonary vein antrum isolation guided by left atrial wall thickness for persistent atrial fibrillation G Falasconi, D Penela, D Soto-Iglesias, P Francia, C Teres, A Saglietto, ... Europace 25 (5), euad118, 2023 | 15 | 2023 |
| Cardiac magnetic resonance to predict recurrences after ventricular tachycardia ablation: septal involvement, transmural channels, and left ventricular mass L Quinto, P Sanchez, F Alarcón, P Garre, F Zaraket, S Prat-Gonzalez, ... EP Europace 23 (9), 1437-1445, 2021 | 15 | 2021 |
| Safety of glycoprotein IIb/IIIa inhibitors in patients under therapeutic hypothermia admitted for an acute coronary syndrome G Jiménez-Brítez, X Freixa, E Flores, D Penela, M Hernandez-Enríquez, ... Resuscitation 106, 108-112, 2016 | 15 | 2016 |
| A standardized stepwise zero-fluoroscopy approach with transesophageal echocardiography guidance for atrial fibrillation ablation G Falasconi, D Penela, D Soto-Iglesias, B Jauregui, A Chauca, ... Journal of Interventional Cardiac Electrophysiology, 1-11, 2022 | 13 | 2022 |
| Management of anticoagulation in patients undergoing leadless pacemaker implantation R San Antonio, F Chipa-Ccasani, J Apolo, M Linhart, O Trotta, ... Heart Rhythm 16 (12), 1849-1854, 2019 | 13 | 2019 |
| Safety and usefulness of a second Micra transcatheter pacemaker implantation after battery depletion P Sánchez, J Apolo, R San Antonio, E Guasch, L Mont, JM Tolosana EP Europace 21 (6), 885-885, 2019 | 9 | 2019 |
| The SGLT2 inhibitor empagliflozin does not exhibit pro thrombotic effects CG Santos-Gallego, M Zafar, RS Antonio, JAR Ibanez, MBP Botija, ... Journal of the American College of Cardiology 71 (11S), A1852-A1852, 2018 | 8 | 2018 |
